Abstract:1 The aim of the present study was to investigate the effects of ethanol in vitro on the phospholipid biosynthetic pathways in hepatocytes isolated from the rat. We have used [methyl-"4C] products of the CDP-choline and CDP-ethanolamine pathways. Radioactivity in the metabolic intermediates of both pathways was significantly decreased and the amount of label in PE was reduced whilst that of PC was not modified. 3 In the presence of 4-methylpyrazole, an inhibitor of alcohol dehydrogenase (ADH) activity, ethanol… Show more
“…In the light of these findings, our previous experience with hepatic cells and research into the action of different xenobiotics on phospholipid metabolism [17,18] has prompted us to investigate the effect of HePC on the tumoral hepatic cell line HepG2. We studied its cytotoxic and cytostatic activity against HepG2 cells and examined its influence on de novo PC biosynthesis by using the precursor [methyl-14 C]choline as radioactive marker.…”
“…In the light of these findings, our previous experience with hepatic cells and research into the action of different xenobiotics on phospholipid metabolism [17,18] has prompted us to investigate the effect of HePC on the tumoral hepatic cell line HepG2. We studied its cytotoxic and cytostatic activity against HepG2 cells and examined its influence on de novo PC biosynthesis by using the precursor [methyl-14 C]choline as radioactive marker.…”
“…In the light of these findings, our previous experience with hepatic cells and research into the action of different xenobiotics on phospholipid metabolism [17,18] has prompted us to investigate the effect of HePC on the tumoral hepatic cell line HepG2. We studied its cytotoxic and cytostatic activity against HepG2 cells and examined its influence on de novo PC biosynthesis by using the precursor [methyl‐ 14 C]choline as radioactive marker.…”
Hexadecylphosphocholine (HePC) is a synthetic lipid representative of a new group of antiproliferative agents, alkylphosphocholines (APC), which are promising candidates in anticancer therapy. Thus we have studied the action of HePC on the human hepatoblastoma cell line HepG2, which is frequently used as a model for studies into hepatic lipid metabolism. Non‐toxic, micromolar concentrations of HePC exerted an antiproliferative effect on this hepatoma cell line. The incorporation into phosphatidylcholine (PC) of the exogenous precursor [methyl‐14C]choline was substantially reduced by HePC. This effect was not due to any alteration in choline uptake by the cells, the degradation rate of PC or the release of PC into the culture medium. As anaccumulation of soluble choline derivatives points to CTP:phosphocholine cytidylyltransferase (CT) as the target of HePC activity we examined its effects on the different enzymes involved in the biosynthesis of PC via CDP–choline. Treatment with HePC altered neither the activity of choline kinase (CK) nor that of diacylglycerol cholinephosphotransferase (CPT), but it did inhibit CT activity in HepG2 cells. In vitro HePC also inhibited the activity of cytosolic but not membrane‐bound CT. Taken together our results suggest that HePC interferes specifically with the biosynthesis of PC in HepG2 cells by depressing CT translocation to the membrane, which may well impair their proliferation.
“…The formation of the phospholipid phosphatidylethanol (PEth) during ethanol exposure has been implicated in the pathogenesis of alcohol-induced organ damage [7]. Hepatic triacylglycerol accumulations have been described in chronic alcoholism [12]; however, reports on the effects of ethanol administration on the biosynthesis of cellular phospholipids are few and contradictory [4,10,16]. Several researchers have found that ethanol affects the incorporation and distribution of various exogenously supplied substrates in different ways.…”
The metabolic fate of ethanol into the phospholipid pool of calf pulmonary artery endothelial cells was studied. [14C]-ethanol was incorporated into various endothelial cell phospholipids including phosphatidylethanol (PEth), which may represent a substantial fraction in microdomains of membrane phospholipids. The incorporation into phospholipids was reduced in the presence of pyrazole and cyanamide, inhibitors of ethanol metabolism. Wortmannin, the phosphatidylinositol 3-kinase inhibitor, increased [14C]-PEth formation. [3H]-acetate was also incorporated into endothelial cell phospholipids but in a different pattern. Distribution of [3H]-acetate and [14C]-ethanol into the fatty acyl moiety versus the glycerophosphoryl backbone of the phospholipids was also different. Stimulation of the endothelial cells with ATP increased [3H]-acetate incorporation into platelet-activating factor (PAF) and ethanol decreased it. Ethanol exposure increased ATP-stimulated [3H]-acetate incorporation into sphingomyelin. However, ATP had no effect on the incorporation of [14C]-ethanol into any phospholipids. The results suggest that the two precursors contribute to a separate acetate pool and that the sphingomyelin cycle may be sensitized in ethanol-treated cells. Thus, metabolic conversions of ethanol into lipids and the effect of ethanol on specific lipid mediators, e.g PAF, PEth and sphingomyelin, may be critical determinants in the altered responses of the endothelium in alcoholism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.